Skip to contentA
Adicet Bio, Inc.
A
ACETAdicet Bio, Inc. Released Mar 12, 2020, before the open
10-K filed Mar 12, 2020, 72 days after period end · 0001564590-20-010474
Q4 2019 · 10-K
Revenue—
Net Income-$28.89M-$28.89MN/M vs Q4 2018N/M vs Q3 2019 EPS Diluted
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR
-$0.79-$0.79N/M vs Q4 2018N/M vs Q3 2019 Operating Income-$29,436,000N/M Operating Cash Flowderived-$7,259,000N/M Free Cash Flowderived-$7,718,000N/M ended Dec 31, 2019 · filed Mar 12, 2020 · 72 d after period end